Add to watch list
Prev Close
0.3061
Today's Open
0.3900
Day's Range
0.3700-0.4050
Volume
33,570
Dollar Volume
$20417.39
Avg Vol(5-day)
90,147
Avg Vol(1-month)
145,622
Nemus Bioscience Logo

http://www.nemusbioscience.com

Description

Nemus Bioscience, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and the commercialization of cannabinoid-based therapeutics through its partnership with the University of Mississippi (UM). It is UM's partner for the development and commercialization of drugs derived from cannabis extracts, or cannabinoids. It is focused primarily on the development of early-stage cannabinoid product candidates, including NB1111, NB1222, NB3111 and NB2111. NB1111, a prodrug of Tetrahydrocannabinol (THC), is in the preclinical stage for the indication of glaucoma. NB1222 is a prodrug formulation of THC and is intended for systemic administration in the management of chemotherapy-induced nausea and vomiting (CINV). The NB2111 formulation technology is designed to permit better transmembrane translocation of cannabinoids. The NB3111 product candidate is in research stage for the indication of Methicillin-resistant Staphylococcus aureus (MRSA).

Company Address

CEO: Brian S. Murphy
650 TOWN CENTER DRIVE SUITE 1770
COSTA MESA, CA 92626
United States
We don't have any subsidiaries for Nemus Bioscience.

Have a suggestion?

Please Contact Us to let us know.